Piergiorgio Messa, Fernando Macário, Magdi Yaqoob, Koen Bouman, Johann Braun, Beat von Albertini, Hans Brink, Francisco Maduell, Helmut Graf, João M Frazão, Willem Jan Bos, Vicente Torregrosa, Heikki Saha, Helmut Reichel, Martin Wilkie, Valter J Zani, Bart Molemans, Dave Carter, Francesco Locatelli
BACKGROUND AND OBJECTIVES: Cinacalcet, a novel calcimimetic, targets the calcium-sensing receptor to lower parathyroid hormone (PTH), calcium, and phosphorus levels in dialysis patients with secondary hyperparathyroidism (SHPT). This study compared the efficacy of a cinacalcet-based regimen with unrestricted conventional care (vitamin D and phosphate binders) for achieving the stringent National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) targets for dialysis patients...
January 2008: Clinical Journal of the American Society of Nephrology: CJASN